Issues with Intravitreal Administration of Anti-VEGF Drugs
Marc Schargus,1,2 Andreas Frings1,3 1Department of Ophthalmology, Heinrich Heine University, Duesseldorf, Germany; 2Department of Ophthalmology, Asklepios Hospital Nord-Heidberg, Hamburg, Germany; 3Augenarztpraxis Dr. Frings, Nuremberg, GermanyCorrespondence: Marc SchargusDepartment of Ophthalmology...
Guardado en:
Autores principales: | Schargus M, Frings A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ee8212c44d6c45a1a1c529de79cc6ef3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evaluation of the prevalence of silicone oil droplets in the vitreous in patients treated with multiple intravitreal drug injections
por: E. V. Bobykin, et al.
Publicado: (2021) -
A comparison in precision and accuracy of the conventional syringe to the Suh precision syringe
por: DeLuna D, et al.
Publicado: (2019) -
Short-Term Non-Infectious Outcomes After a Pars Plana Intravitreal Antibiotic-Steroid Injection of Triamcinolone, Moxifloxacin, and Vancomycin During Cataract Surgery versus a Standard Postoperative Topical Regimen
por: Haq Z, et al.
Publicado: (2020) -
Prefilled syringes for intravitreal drug delivery
por: Sassalos TM, et al.
Publicado: (2019) -
Short-Term Changes in Intraocular Pressure After Intravitreal Injection of Bevacizumab for the Treatment of Retinopathy of Prematurity
por: Obata S, et al.
Publicado: (2019)